Daniel Zhang

9PUBLICATIONS
29CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Microbial taxonomyGene and molecular therapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 23, 2023
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade.

Crismita Dmello, Junfei Zhao, Li Chen

|May 13, 2022
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma.

Crismita Dmello, Aarón Sonabend, Victor A Arrieta

|Feb 05, 2022
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.

Víctor A Arrieta, Andrew X Chen, J Robert Kane

|Aug 26, 2021
TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human Gliomas.

Edgar Gonzalez-Buendia, Junfei Zhao, Lu Wang

|May 25, 2021
Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models.

Aria Sabbagh, Kevin Beccaria, Xiaoyang Ling

|Jun 13, 2020
Ribosomal protein S11 influences glioma response to TOP2 poisons.

Chidiebere U Awah, Li Chen, Mukesh Bansal

Pageof 2

Frequent Collaborators

7 joint publications

Adam M Sonabend

3 joint publications

Brice Laffleur

3 joint publications

Raul Rabadan

3 joint publications

Amy B Heimberger